MTOR and Miyoshi myopathy: Moreover they demonstrated that miR-451 activated the PI3K/Akt/mTOR pathway in SP cells through its target tuberous sclerosis 1 (TSC1), this pathway is a well-known oncogenic pathway in cancers including MM [78-80].